ID: ALA116883
Chembl Id: CHEMBL116883
PubChem CID: 10596595
Max Phase: Preclinical
Molecular Formula: C18H24Cl2O5
Molecular Weight: 391.29
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)CC(O)(CCCCCCCCc1ccc(Cl)cc1Cl)C(=O)O
Standard InChI: InChI=1S/C18H24Cl2O5/c19-14-9-8-13(15(20)11-14)7-5-3-1-2-4-6-10-18(25,17(23)24)12-16(21)22/h8-9,11,25H,1-7,10,12H2,(H,21,22)(H,23,24)
Standard InChI Key: DWDZPBYZECADBQ-UHFFFAOYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 391.29 | Molecular Weight (Monoisotopic): 390.1001 | AlogP: 4.56 | #Rotatable Bonds: 12 |
| Polar Surface Area: 94.83 | Molecular Species: ACID | HBA: 3 | HBD: 3 |
| #RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 3.85 | CX Basic pKa: ┄ | CX LogP: 5.30 | CX LogD: 0.33 |
| Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.45 | Np Likeness Score: 0.15 |
| 1. Gribble AD, Dolle RE, Shaw A, McNair D, Novelli R, Novelli CE, Slingsby BP, Shah VP, Tew D, Saxty BA, Allen M, Groot PH, Pearce N, Yates J.. (1996) ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme., 39 (18): [PMID:8784456] [10.1021/jm960167w] |
| 2. Granchi C.. (2018) ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism., 157 [PMID:30195238] [10.1016/j.ejmech.2018.09.001] |
Source(1):
